Kodiak Sciences Inc. - 8-K Filing
Kodiak Sciences announced positive Phase 3 results for both Zenkuda and tabirafusp-ted, meeting primary endpoints in the treatment of wet age-related macular degeneration. (Items: 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $KOD